BNP Paribas Issuance News - P18U91

Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII)

http://www.tickerreport.com/banking-finance/501588/sarepta-therapeutics-upgraded-to-outperform-at-robert-w-baird-avii/?utm_source=ADVFN&utm_medium=...

Booming Biotechnology Industry Continues to Impress Investors in 2012

NEW YORK, NY -- (Marketwire) -- 07/12/12 -- Despite the recent economic slowdown, the Biotech Industry has been home to some of the strongest...

AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today

BOTHELL, WA -- (Marketwire) -- 07/12/12 -- AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it has changed its name to Sarepta...

- Amended Statement of Ownership (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) AVI BIOPHARMA...

AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference

BOTHELL, WA -- (Marketwire) -- 07/06/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today that it is...

- Proxy Statement (definitive) (DEF 14A)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

BOTHELL, WA -- (Marketwire) -- 06/01/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced today that it...

Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release

CORAL SPRINGS, FL -- (Marketwire) -- 05/11/12 -- FinancialNewsMedia.com "stocks to watch" for today: Avatar Ventures Corp. (OTCBB: AVVC), Google...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT...

AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments

BOTHELL, WA -- (Marketwire) -- 05/10/12 -- AVI BioPharma, Inc. (NASDAQ: AVII) Duchenne Muscular Dystrophy (DMD) and Infectious Disease Programs...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q...

U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit

NEW YORK, NY -- (Marketwire) -- 05/04/12 -- Biotech stocks have continued to provide investors with strong gains in 2012. The iShares NASDAQ...

Zacks #1 Rank Additions for Friday - Tale of the Tape

Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: ACCO Brands Corp. (ACCO) AMETEK, Inc...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BNP Paribas Issuance (P18U91)

Empower your portfolio: Real-time discussions and actionable trading ideas.

P18U91 News

Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII)

Booming Biotechnology Industry Continues to Impress Investors in 2012

AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today

- Amended Statement of Ownership (SC 13G/A)

AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference

- Proxy Statement (definitive) (DEF 14A)

- Current report filing (8-K)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release

- Current report filing (8-K)

AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments

- Quarterly Report (10-Q)

U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit

Zacks #1 Rank Additions for Friday - Tale of the Tape

P18U91 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

BNP Paribas Issuance (P18U91) News

BNP Paribas Issuance (P18U91)

Empower your portfolio: Real-time discussions and actionable trading ideas.

P18U91 News

Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII)

Booming Biotechnology Industry Continues to Impress Investors in 2012

AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today

- Amended Statement of Ownership (SC 13G/A)

AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference

- Proxy Statement (definitive) (DEF 14A)

- Current report filing (8-K)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release

- Current report filing (8-K)

AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments

- Quarterly Report (10-Q)

U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit

Zacks #1 Rank Additions for Friday - Tale of the Tape

P18U91 Discussion

Your Recent History